insulin dosing & therapeutic inertia in the time of covid-19
Published 4 years ago • 500 plays • Length 47:29Download video MP4
Download video MP3
Similar videos
-
50:35
tackling therapeutic inertia: american diabetes association standard of care updates
-
50:25
diabetes patient needs in the time of covid-19
-
57:39
continuous glucose monitoring (cgm) & beyond a1c targets in the time of covid-19
-
45:58
diabetes & exercise in the time of covid-19
-
52:47
diabetes distress & coping in the time covid-19
-
47:09
dpp-4 inhibitor, glp-1 receptor agonist, & sglt inhibitor therapies in the time of covid-19
-
51:56
identifying high-risk diabetes patients for covid-19 triage
-
21:32
stanford medcast - episode1: covid-19 mini-series - management of diabetes patients in covid
-
46:12
covid-19 & sick day management for people with diabetes
-
50:44
diabetes and pregnancy in the time of covid-19
-
51:24
diabetes disparities in the time of covid-19
-
1:11:02
review of the literature regarding knowledge gained on covid-19 and diabetes
-
48:27
platforms to support remote diabetes monitoring in your practice in the time of covid-19
-
52:38
diabetes & substance abuse in the time of covid-19 | dea mate act training course
-
47:01
leveraging telehealth and remote monitoring to support patients with diabetes
-
10:23
john w. kennedy, md: tools and resources for primary care providers dealing with diabetes
-
6:10
jay h. shubrook, do: meaningful visits with your patients
-
10:24
therapeutic inertia: what you need to know
-
44:57
nuts & bolts of remote insulin adjustment and diabetes education